Low risk of chronic graft-versus-host disease and relapse associated with T cell-depleted peripheral blood stem cell transplantation for acute myelogenous leukemia in first remission: results of the blood and marrow transplant clinical trials networ

Low risk of chronic graft-versus-host disease and relapse associated with T cell-depleted peripheral blood stem cell transplantation for acute myelogenous leukemia in first remission: results of the blood and marrow transplant clinical trials networ

Item

http://www.wikidata.org/entity/Q35148420

Q35148420

about

The Blood and Marrow Transplant Clinical Trials Network: An Effective Infrastructure for Addressing Important Issues in Hematopoietic Cell Transplantation Effects of T-Cell Depletion on Allogeneic Hematopoietic Stem Cell Transplantation Outcomes in AML Patients Graft-versus-host disease: why have we not made more progress?Current translational and clinical practices in hematopoietic cell and gene therapy Recent Developments in Cellular Immunotherapy for HSCT-Associated Complications Long term renal survival in patients undergoing T-Cell depleted versus conventional hematopoietic stem cell transplants.Palifermin is efficacious in recipients of TBI-based but not chemotherapy-based allogeneic hematopoietic stem cell transplants.Ex vivo T cell-depleted versus unmodified allografts in patients with acute myeloid leukemia in first complete remission.Multicenter phase II study of a combination of cyclosporine a, methotrexate and mycophenolate mofetil for GVHD prophylaxis: results of the Chinese Bone Marrow Transplant Cooperative Group (CBMTCG).Single-agent GVHD prophylaxis with posttransplantation cyclophosphamide after myeloablative, HLA-matched BMT for AML, ALL, and MDS.How we treat chronic graft-versus-host disease.Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research.Engineering human peripheral blood stem cell grafts that are depleted of naïve T cells and retain functional pathogen-specific memory T cells.Modified extracorporeal photopheresis with cells from a healthy donor for acute graft-versus-host disease in a mouse model Comparison of outcomes at two institutions of patients with ALL receiving ex vivo T-cell-depleted or unmodified allografts.Prolonged sirolimus administration after allogeneic hematopoietic cell transplantation is associated with decreased risk for moderate-severe chronic graft-versus-host disease Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies.Outcomes of acute leukemia patients transplanted with naive T cell-depleted stem cell grafts.Have we improved in preventing and treating acute graft-versus-host disease?Comparative outcomes of donor graft CD34+ selection and immune suppressive therapy as graft-versus-host disease prophylaxis for patients with acute myeloid leukemia in complete remission undergoing HLA-matched sibling allogeneic hematopoietic cell t Heparan sulfate, an endogenous TLR4 agonist, promotes acute GVHD after allogeneic stem cell transplantation CD34+ selection and the severity of oropharyngeal mucositis in total body irradiation-based allogeneic stem cell transplantation Adenovirus Viremia in Adult CD34(+) Selected Hematopoietic Cell Transplant Recipients: Low Incidence and High Clinical Impact.CD34-Selected Hematopoietic Stem Cell Transplants Conditioned with Myeloablative Regimens and Antithymocyte Globulin for Advanced Myelodysplastic Syndrome: Limited Graft-versus-Host Disease without Increased Relapse Allogeneic transplantation: peripheral blood vs. bone marrow.Concise review: acute graft-versus-host disease: immunobiology, prevention, and treatment.Circulating T follicular helper cells with increased function during chronic graft-versus-host disease Strategies to reduce relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia.Histopathologic Features of Cutaneous Acute Graft-Versus-Host Disease in T-Cell-Depleted Peripheral Blood Stem Cell Transplant Recipients.Characteristics of CliniMACS® System CD34-enriched T cell-depleted grafts in a multicenter trial for acute myeloid leukemia-Blood and Marrow Transplant Clinical Trials Network (BMT CTN) protocol 0303 Advances in the treatment of acute graft-versus-host disease.Stem cell transplantation in adults with acute myelogenous leukemia, normal cytogenetics, and the FLT3-ITD mutation.T cell-depleted stem cell transplantation for adults with high-risk acute lymphoblastic leukemia: long-term survival for patients in first complete remission with a decreased risk of graft-versus-host disease.The road to purified hematopoietic stem cell transplants is paved with antibodies.Mixed chimerism in haemoglobinopathies: from risk of graft rejection to immune tolerance.T-cell depleted allogeneic hematopoietic cell transplants as a platform for adoptive therapy with leukemia selective or virus-specific T-cells.Immunotherapy in acute myeloid leukemia.The evolution of T-cell depletion in haploidentical stem-cell transplantation.Ex vivo T-cell depletion in allogeneic hematopoietic stem cell transplant: past, present and future.Early recovery of T-cell function predicts improved survival after T-cell depleted allogeneic transplant.

P2860

Q26740251-7383DC3A-5704-45C9-BF93-47904457E56C Q26799602-1B3E0F3B-D0A2-4DE7-BCE3-C3B977D85DBF Q27012940-4FF54DAB-08D7-4FF0-B005-B1B2F4212618 Q27024456-A2CF5F31-2121-45A6-BB04-878CA40EDE58 Q28079823-378B7144-8ECB-46C2-86A0-F46085B8B67D Q33633514-6FC9D0A0-866A-4D2F-96FF-DC3F51EB24D6 Q33745865-334F0927-3CA3-464F-A47D-8E42F27B38A9 Q33760933-24EFE62B-1894-4282-9529-034F9EEBF84F Q34544439-926C3C88-1A57-4939-95EE-F410D2C0A845 Q34684038-79E31C06-B677-484C-9660-0017342FC270 Q35004923-26485CDD-81D2-420A-9FBE-F3C56185C9E2 Q35078368-1D843B08-6FB2-4E7E-84E1-C52510584EE4 Q35094029-6F8E051D-6218-4E2C-808D-B9020E1CB434 Q35229872-25DF9BC3-C789-483B-BF96-206E24DA72DD Q35243578-D307DF47-DE31-4E83-9120-3FC80B967C04 Q35800856-2E6B3580-FFE7-43F3-AB43-A427D612C46E Q35925091-CC29CC78-7580-45F6-B416-56C7188C1880 Q36040293-24EABCD0-AA5C-413D-BF5E-0AC80AE740A8 Q36203692-D718DF92-B793-4CC5-8F5D-CABD4E653FA0 Q36212392-750875F9-2BB6-415F-B737-E5C911FB3A19 Q36305350-E283EB92-6D74-4B6A-959C-2A518D278F45 Q36403184-820B66DE-65B5-41C5-BFB4-2C8C8AC6089A Q36445556-7284F508-5EC5-4783-8E10-0E56BC132A5B Q36608689-07AEB1B9-7A21-4372-8E84-E1514E3F199B Q36761427-6ACBB2F1-C7FF-48DB-AD9E-F42A9DD68F85 Q36861714-F320AE6F-B930-4BAB-8A78-D02A26D23CD4 Q36920466-E9D9ECDD-ECAF-4ACF-8998-31B7F72713EB Q37000485-21FAA6A6-7FCC-4A8B-AA8B-8A21710CDA24 Q37139105-02D856F5-AF0A-4B61-BA53-C69838F7D2B3 Q37145293-B015D79A-8E60-4286-B407-1F337BE04C5E Q37191057-F62048EF-2E96-4329-8143-6C27D274EE51 Q37316816-68CEA931-2ACF-40ED-A3AD-0E21B3460F42 Q37659142-E4353E2A-CDC5-43D3-A8CB-1295F4AFB234 Q38039703-B9709886-84F5-4BA5-8180-AF0DE4B99120 Q38191280-EA1DBF09-D00B-49D5-A870-01406984ECC4 Q38514497-8ACA085D-DE8E-4863-A1AF-2B69370EA7A2 Q38533606-D853D17D-6ADA-4821-9612-CB71961F8555 Q38673780-3B01EDE2-1CA8-4C8C-ABFF-8962C4D31B27 Q38742867-403F7E93-CC8E-4E63-A63B-2B1FF3F005E4 Q39028818-9F4C664B-422F-45BA-A780-5C2DE029CF5D

P2860

Low risk of chronic graft-versus-host disease and relapse associated with T cell-depleted peripheral blood stem cell transplantation for acute myelogenous leukemia in first remission: results of the blood and marrow transplant clinical trials networ

Item

http://www.wikidata.org/entity/Q35148420

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu